November 2023 FDA Recall Drug by Right Value Drug Stores, Llc Dba Carie Boyd's Prescription Shop
D-0140-2024 - Product Mix-up

This Class III drug recall was voluntarily initiated by Right Value Drug Stores, Llc Dba Carie Boyd's Prescription Shop on November 9, 2023 for the product Drug. The FDA reported the reason for recall as product mix-up. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0140-2024

Reason for Recall
Product Mix-up: Incorrect Product Formulation
Initiated
11-09-2023
Reported
12-13-2023
Quantity
190 syringes

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
93316
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Distribution Pattern About Distribution Pattern
General area of initial distribution.
USA Nationwide
Termination Date About Termination Date
Date that FDA officially terminated the recall.
08-20-2024
Product Description About Product Description
Full technical description of the product.
LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

Batch or Lot Expiration Information

Lot# : 09202023@7, Exp 03/18/2024